Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 9;12(22):7008.
doi: 10.3390/jcm12227008.

The Influence of Time on the Epidemiology and Clinical Manifestations of Behçet's Disease in Brazil

Affiliations

The Influence of Time on the Epidemiology and Clinical Manifestations of Behçet's Disease in Brazil

Lilian T Hirata et al. J Clin Med. .

Abstract

Objective: Modifications in the severity and clinical expression of Behçet's disease (BD) have been described in some areas that are considered endemic for the disease. This study aims to evaluate the chronological changes in epidemiology and clinical characteristics of BD patients in a referral center in Brazil, which is considered a non-endemic area for the disease.

Methods: A descriptive and cross-sectional study involving BD patients divided into two groups: group 1 patients were diagnosed and followed between 1988 and 2010, and group 2 were diagnosed and followed between 2011 and 2022.

Results: No significant differences were found regarding gender and age at onset of symptoms between groups. We found a significant decrease in the frequency of bilateral ocular involvement, posterior uveitis, and retinal vasculitis.

Conclusion: The demographic dates of this group of Brazilian BD patients remained similar over the last decade. Our study supports the notion that BD is becoming lighter in some regions. BD is a severe blinding disorder, and we found a lower frequency of ocular involvement over time. These findings may be attributed to a higher level of education of patients and a growing awareness of the disease. Newer immunomodulating and biologic agents may offer an improved prognosis in patients with BD with severe manifestations.

Keywords: Behçet’s disease; clinical manifestations; epidemiology; vasculitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Yazici H., Seyahi E., Hatemi G., Yazici Y. Behçet syndrome: A contemporary view. Nat. Rev. Rheumatol. 2018;14:107–119. doi: 10.1038/nrrheum.2017.208. - DOI - PubMed
    1. Tan S.Y., Poole P.S. Hulusi Behçet (1889–1948): Passion for dermatology. Singap. Med. J. 2016;57:408–409. doi: 10.11622/smedj.2016123. - DOI - PMC - PubMed
    1. Watts R.A., Hatemi G., Burns J.C., Mohammad A.J. Global epidemiology of vasculitis. Nat. Rev. Rheumatol. 2022;18:22–34. doi: 10.1038/s41584-021-00718-8. - DOI - PMC - PubMed
    1. Ozguler Y., Esatoglu S.N., Hatemi G. Epidemiology of systemic vasculitis. Curr. Opin. Rheumatol. 2023 doi: 10.1097/BOR.0000000000000983. - DOI - PubMed
    1. Belem J.M.F.M., Pereira R.M.R., Perez M.O., Prado L.L.D., Calich A.L., Sachetto Z., Bacchiega A.B.S., Simil F.F., Pedreira A.L., Gazzeta M.O., et al. Epidemiologic Features of Systemic Vasculitides in the Southeast Region of Brazil: Hospital-Based Survey. J. Clin. Rheumatol. 2020;26:S106–S110. doi: 10.1097/RHU.0000000000001041. - DOI - PubMed

LinkOut - more resources